- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
Modified Growth Hormone Fragment · Educational Resource
Understanding AOD-9604 and Metabolic Research
Modified GH Fragment (176-191)
(Synthetic Peptide)
Investigational Application
Fat metabolism research
Administration Protocol
Subcutaneous (subQ), per study protocol
Want to learn more?
A licensed team will reach out to guide you through the research.
Book a consultation →Modified Growth Hormone Fragment · Educational Resource
Understanding AOD-9604 and Metabolic Research
01 — Overview
What is AOD-9604?
AOD-9604 is a synthetic peptide representing a modified fragment of the human growth hormone (hGH) molecule, specifically the 176-191 amino acid region, engineered to isolate a specific region of interest from the full hormone.
As an investigational compound, AOD-9604 has not received regulatory approval for therapeutic use in the Philippines or elsewhere. It should be understood strictly as a research compound studied in preclinical and early-phase contexts.
Within research literature, AOD-9604 is most frequently studied for its relationship to lipid metabolism and fat oxidation pathways, areas summarized further below.
02 — How it works
How It Works: Modified Growth Hormone Fragment Signaling and Lipid Metabolism
As a modified fragment of human growth hormone, AOD-9604 is designed to isolate the region of the hGH molecule researchers associate with lipolytic activity, without replicating the full hormone's broader receptor-binding profile.
Literature describes this fragment-specific approach as a mechanism studied for its narrower research profile relative to full-length growth hormone administration.
Administration in Research
In preclinical and early-phase literature, AOD-9604 is evaluated as a subcutaneous injection administered according to study-specific protocols. As an investigational compound, it has not received regulatory approval for therapeutic use, and research contexts differ from any at-home or self-directed use.
03 — Areas of research
Summary of Investigated Research Areas
Preclinical and early-phase literature evaluates AOD-9604 across several key physiological parameters to map its biological interactions:
Lipolysis Pathway Signaling
Research literature evaluates how this modified GH fragment influences lipolytic pathways without the broader growth-hormone receptor activation profile of full-length hGH.
Fat Metabolism Parameters
Preclinical studies observe markers of fat oxidation and lipid metabolism following AOD-9604 administration in research models.
Body Composition Studies
Investigational literature reports on body composition measures tracked over controlled study periods.
Metabolic Rate Markers
Studies examine indicators of metabolic rate associated with modified GH fragment exposure in research settings.
Cartilage and Tissue Research
Some literature explores this fragment's relationship to tissue-level research distinct from its metabolic study focus.
Pharmacokinetic Profiling
Early-phase studies characterize the absorption and elimination profile of AOD-9604 in research settings.
04 — FAQ
Frequently Asked Questions
Ano ba talaga ang AOD-9604?
Ang AOD-9604 ay isang modified fragment ng human growth hormone (hGH), partikular ang 176-191 amino acid region. Pinag-aaralan ito sa research para sa posibleng kaugnayan sa fat metabolism. Educational discussion lang ito, hindi sales o medical advice.
FDA-approved ba ito?
Hindi. Ang AOD-9604 ay fully investigational compound na wala pang regulatory approval para sa therapeutic use kahit saan.
Bakit fragment lang ng hGH, hindi buong hormone?
Dinisenyo ang fragment na ito para isolate lamang ang region na may kaugnayan sa lipolytic activity, iniiwasan ang mas malawak na epekto ng buong growth hormone molecule sa literature.
Pwede ba akong bumili nito dito?
Ang page na ito ay para sa educational purposes lamang. Hindi kami nagbebenta ng peptides dito online — kausapin ang isang lisensyadong healthcare provider para sa tamang gabay.
05 — References
References and Academic Literature
Heffernan, M., et al. (2001). The Effects of Human GH and Its Lipolytic Fragment (AOD9604) on Lipid Metabolism Following Chronic Treatment in Obese Mice. Endocrinology.
Ng, F.M., et al. (2000). Metabolic Studies of a Synthetic Lipolytic Domain (AOD9604) of Human Growth Hormone. Hormone and Metabolic Research.
Heffernan, M.A., et al. (2001). Increase of Fat Oxidation and Weight Loss in Obese Mice Caused by Chronic Treatment with Human Growth Hormone or a Modified Fragment. International Journal of Obesity.
i
Medical Education Disclaimer: This page is intended strictly for educational and informational purposes regarding the scientific history and development of chemical compounds. It does not constitute medical advice, promotion, or advertising of any prescription medication. Any therapeutic applications must be evaluated and managed exclusively by a licensed medical practitioner.
Getting started
How to Get Started?
1. Consult
Book a free consultation with our licensed healthcare team.
100 % online. Hassle-free. Convenient.
2. Real Human Assessment
Talk with Philippine-licensed doctors and get prescribed.
Always doctor-led—never just an online form.
Free consultation with licensed providers
3. Start your Program
Your medication is prepared and delivered to your doorstep.
No lock-ins. No hidden fees. No subscriptions.
Formulated in FDA-regulated pharmacies
4. Consistent care
Stay on track with regular weekly follow-ups. On your chosen communication platform.
Unlimited complementary follow-ups